Vaccines for COVID-19: A Review of Feasibility and Effectiveness

Author:

Mehraeen Esmaeil1,Dadras Omid2,Afsahi Amir Masoud3,Karimi Amirali4,MohsseniPour Mehrzad5,Mirzapour Pegah5,Barzegary Alireza6,Behnezhad Farzane7,Habibi Pedram5,Salehi Mohammad Amin5,Vahedi Farzin4,Heydari Mohammad1,Kianzad Shaghayegh8,Moradmand-Badie Banafsheh9,Javaherian Mohammad10,SeyedAlinaghi SeyedAhmad5,Sabatier Jean-Marc11

Affiliation:

1. Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran

2. Department of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

3. Department of Radiology, School of Medicine, University of California, San Diego [UCSD], California, United States

4. School of medicine, Tehran University of Medical Sciences, Tehran, Iran

5. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran

6. School of medicine, Islamic Azad University, Tehran, Iran

7. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

8. School of Medicine, Iran University of Medical Sciences, Tehran ‎7134845794, Iran

9. Black Dog Institute, University of New South Wales, Sydney, Australia

10. Department of Physiotherapy, Tehran University of Medical Sciences, Tehran, Iran

11. Université Aix-Marseille, Institut deNeuro-physiopathologie [INP],UMR 7051, Faculté de Pharmacie,27 Bd Jean Moulin, 13385Marseille Cedex, France

Abstract

Introduction: Many potential vaccines for COVID-19 are being studied, and several studies have reported the results of these vaccines. We aimed to review the current evidence of the feasibility and effectiveness of Vaccines for COVID-19. Methods: A search was carried out utilizing the keywords in the online databases, including Scopus,Web of Science, PubMed, Embase, and Cochrane. We included both human and non-human studies because of the vaccine novelty, which could limit our ability to include sufficient human studies. Results: The review of studies showed that several SARS-CoV-2 vaccines are under development; different platforms are being used, including eight vaccines are adenovirus-based vectors, six vaccines are RNA-based formulations, one vaccine is DNA-based formulations, and other vaccines are using other platforms, including lipid nano particles. Conclusion: It is crucial to gather as much clinically relevant evidence as possible regarding the immunogenicity, efficacy, and safety profiles of these vaccines and adhere wisely to CDC protocols and guidelines of vaccine production.

Publisher

Bentham Science Publishers Ltd.

Subject

Microbiology (medical),Pharmacology,Molecular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3